Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;24(4):324-331.
doi: 10.5213/inj.2040108.054. Epub 2020 Dec 31.

Catheter-Related Bladder Discomfort: How Can We Manage It?

Eun Bi Jang  1   2 , Seong Hwi Hong  1 , Kyu Shik Kim  1 , Sung Yul Park  1 , Yong Tae Kim  1 , Young Eun Yoon  1 , Hong Sang Moon  1
Affiliations

Catheter-Related Bladder Discomfort: How Can We Manage It?

Eun Bi Jang et al. Int Neurourol J. 2020 Dec.

Abstract

The urethral catheter is used in various clinical situations such as diagnosing urologic disease, urine drainage in patients after surgery, and for patients who cannot urinate voluntarily. However, catheters can cause numerous adverse effects, such as catheter-associated infection, obstruction, bladder stones, urethral injury, and catheter-related bladder discomfort (CRBD). CRBD symptoms vary among patients from burning sensation and pain in the suprapubic and penile areas to urinary urgency. CRBD significantly reduces patient quality of life and can lead to several complications. CRBD is caused by catheter-induced bladder irritation due to muscarinic receptor-mediated involuntary contractions of bladder smooth muscle and also can be caused by mechanical stimulus of the urethral catheter. Various pharmacologic studies for managing CRBD, including antimuscarinic and antiepileptic agents and botulinum toxin injections have been reported. If urologists can reduce patients' CRBD, their quality of life and recovery can improve.

Keywords: Muscarinic antagonist; Urinary bladder; Urinary catheter.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

HSM, the editor-in-chief of International Neurourology Journal, is the co-corresponding author of this article. However, he played no role whatsoever in the editorial evaluation of this article or the decision to publish it. Except for that, no potential conflict of interest relevant to this article was reported.

References

    1. Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med. 1982;307:637–42. - PubMed
    1. Lo E, Nicolle L, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S41–50. - PubMed
    1. Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol. 2008;29:785–814. - PMC - PubMed
    1. Garcia MM, Gulati S, Liepmann D, Stackhouse GB, Greene K, Stoller ML. Traditional Foley drainage systems--do they drain the bladder? J Urol. 2007;177:203–7. discussion 7. - PubMed
    1. Stickler DJ, Feneley RC. The encrustation and blockage of longterm indwelling bladder catheters: a way forward in prevention and control. Spinal Cord. 2010;48:784–90. - PubMed

LinkOut - more resources